Relative efficacy of GLP-1 and GLP-1/GIP receptor agonists in the prevention of alcohol-use disorders using a target trial emulation approach
Henney AE, Riley DR, Heague M, et al.
Diabetes Obes Metab. Pub. online 7 Oct 2025.
Leggi
Breaking news
Weight loss in people with type 1 diabetes over 12 months: real-world data comparing tirzepatide, semaglutide and liraglutide
Al Ozairi E, Irshad M, Alkandari J, et al.
Diabetes Obes Metab. Pub. online 6 Oct 2025.
Leggi
Medication use in type 1 diabetes and the association with socioeconomic disadvantage: analysis of a national linked dataset
Zomer E, Morton JI, Chen L, et al.
Diabetes Technol Ther. Pub. online 3 Oct 2025.
Leggi
Addressing unmet needs for chronic kidney disease treatment in type 1 diabetes: a review
Tuttle KR, Ji L, Mathieu C, Rosen J
Diabetes Obes Metab. Pub. online 6 Oct 2025.
Leggi
The future of type 1 diabetes therapy
Ziegler AG, Cengiz E, Kay TWH
Lancet. Pub. online 4 Oct 2025.
Leggi
Lack of association between hemoglobin A1c and continuous glucose monitor metrics among individuals with prediabetes and normoglycemia
Rodriguez JA, Palermo NE, Song W, et al.
Diabetes Technol Ther. Pub. online 1 Oct 2025.
Leggi
Efficacy and safety of once-weekly basal insulin therapy in people with type 1 diabetes: a systematic review and meta-analysis
Di Gioia L, Di Molfetta S, Caruso I, et al.
Diabetes Obes Metab. Pub. online 6 Oct 2025.
Leggi
Dapagliflozin reduces epicardial adipose tissue in patients with heart failure and type 2 diabetes
Alghamdi M, Dihoum A, Hakami K, et al.
Diabetes Obes Metab. Pub. online 6 Oct 2025.
Leggi
Association between gestational diabetes mellitus and postpartum depression: an updated systematic review and meta-analysis
Nourollahi Z, Azami M
Diabetes Res Clin Pract. 2025:112922.
Leggi
Inflammation and cardiovascular disease: 2025 ACC Scientific Statement: a report of the American College of Cardiology
Mensah GA, Arnold N, Prabhu SD, et al.
J Am Coll Cardiol. Pub. online 29 Sep 2025.
Leggi